Whitby Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WHITBY, and what generic and branded alternatives to WHITBY drugs are available?
WHITBY has two approved drugs.
Drugs and US Patents for Whitby
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Whitby | THEOBID | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 085983-001 | Mar 20, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Whitby | THEOBID JR. | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087854-001 | Mar 20, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.